WAIKOLOA, Hawaii — At Hawaiian Eye, Mark Packer, MD, discusses the results of a post-FDA approval study of the Trulign accommodating toric IOL (Bausch + Lomb). He noted the results were similar to the FDA trial results, even with less stringent surgical parameters.
WAIKOLOA, Hawaii — At Hawaiian Eye/Retina 2016, Kevin J. Corcoran, COE, CPC, FNAO, CPMA, president of the Corcoran Consulting Group, gives an update on this year’s important coding changes in ophthalmology.
WAIKOLOA, Hawaii — At Hawaiian Eye/Retina 2016, Rishi P. Singh, MD, discusses how to gain mentors and how they can help the ophthalmologist’s career.
WAIKOLOA, Hawaii — Andrew G. Lee, MD, chairman of ophthalmology at Blanton Eye Institute at Houston Methodist Hospital, Texas, was named Speaker of the Day for the Comprehensive Ophthalmology Program for his panel discussion with Randy H. Kardon, MD, PhD, and Grant T. Liu, MD, on neuro-ophthalmology case reviews, as well as Speaker of the Day for the Nurse & Allied Health Program for his talk on neuro-ophthalmology. Nisha Acharya, MD, MS , director of the Uveitis Service and the Uveitis Fellowship at the F.I. Proctor Foundation, California, was named (Read more...)
WAIKOLOA, Hawaii — One uveitis specialist has changed her practice and begun using topical difluprednate as an option for initial therapy for uveitic macular edema. “There are a lot of different options for treating macular edema. We have drops, we have non-steroidal anti-inflammatory drops, we have steroids in many, many forms,” Nisha Acharya, MD, MS, said at Retina 2016. “We know steroids are very effective for both uveitis and for macular edema, but of course they come with known and expected side effects.”
WAIKOLOA, Hawaii — OCT has revolutionized how uveitic patients with cystoid macular edema are treated, according to Thomas A. Albini, MD, who related “Tips from the uveitis clinic” for his colleagues at Retina 2016.“I get a lot of OCTs in the uveitis clinic. Any patient who doesn’t have 20/20 vision, I’m suspicious of uveitic cystoid macular edema, which is the driving force behind vision loss in a lot of uveitis entities. I want to be aware of whether they do have macular edema; it does change my treatment and how (Read more...)